Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berkeley N Limketkai
Jean-Frederic Colombel

Showing results (1-10 of 584) with videos related to

Pageof 59
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 22, 2018
ReplyBerkeley N Limketkai, Jean-Frederic Colombel
Gut|March 30, 2019
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysisBerkeley N Limketkai, Shailja C Shah, Ikuo Hirano, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2019
IBD hospitalisation trends provide insight for future studyBerkeley N Limketkai
Inflammatory Bowel Diseases|March 1, 2023
Reply: Plant-Based Diet Recommended for Inflammatory Bowel DiseaseBerkeley N Limketkai
NEJM Evidence|February 6, 2024
Biologic Treatment Withdrawal: Two Sides of a CoinBerkeley N Limketkai
Gut|November 14, 2018
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
The Lancet. Gastroenterology & Hepatology|December 15, 2019
Biological therapy and recurrent cancer: a threat no more?Berkeley N Limketkai
Inflammatory Bowel Diseases|November 12, 2024
Stricturing Crohn's Disease: When Biologics May Help or Not?Kush Fansiwala, Berkeley N Limketkai
Current Pharmaceutical Design|November 13, 2015
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative ColitisAlyssa Parian, Berkeley N Limketkai
Inflammatory Bowel Diseases|May 23, 2020
Implications of Dietary Impact on Hepatic Steatosis and IBDYejoo Jeon, Berkeley N Limketkai
Pageof 59

Showing results (1-10 of 584) with videos related to

Sort By:
Pageof 59
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 22, 2018
ReplyBerkeley N Limketkai, Jean-Frederic Colombel
Gut|March 30, 2019
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysisBerkeley N Limketkai, Shailja C Shah, Ikuo Hirano, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2019
IBD hospitalisation trends provide insight for future studyBerkeley N Limketkai
Inflammatory Bowel Diseases|March 1, 2023
Reply: Plant-Based Diet Recommended for Inflammatory Bowel DiseaseBerkeley N Limketkai
NEJM Evidence|February 6, 2024
Biologic Treatment Withdrawal: Two Sides of a CoinBerkeley N Limketkai
Gut|November 14, 2018
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
The Lancet. Gastroenterology & Hepatology|December 15, 2019
Biological therapy and recurrent cancer: a threat no more?Berkeley N Limketkai
Inflammatory Bowel Diseases|November 12, 2024
Stricturing Crohn's Disease: When Biologics May Help or Not?Kush Fansiwala, Berkeley N Limketkai
Current Pharmaceutical Design|November 13, 2015
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative ColitisAlyssa Parian, Berkeley N Limketkai
Inflammatory Bowel Diseases|May 23, 2020
Implications of Dietary Impact on Hepatic Steatosis and IBDYejoo Jeon, Berkeley N Limketkai
Pageof 59